COVID-19 new coronavirus vaccine, thermometer and medical mask
Illustrative photo: from open sources
It is known that now the Kazakh vaccine QazCovid-in is being tested in the third phase. The tribune.kz website has sent a number of requests about this to the Ministry of Education and Science. According to the Science Committee of the Ministry, an article is being written about the domestic vaccine in a world scientific journal, as well as,you can read in this material about the degree in which the domestic vaccine will be transported,.
– Currently,it is known that the QazCovid-in vaccine is being tested at the third stage. It is reported that 3,000 people will take part for this inspection. How many of these people were vaccinated? What is their condition? This is a very small amount of compared to the Pfizer-Biontech’s 43,000 volunteers participated in the third phase of the vaccine and 30,000 volunteers participated in the third phase of the Moderna vaccine. Is it possible to draw convincing conclusions from these 3,000 people? Does it affect the trust of the people?
– Judging by the data and recommendations on the website of the World Health Organization, we see that in some countries of the world, vaccines that have reached 3-phase clinical trials have been carried out by 1,000 people. Therefore, our research is also conducted on the basis of world experience.
– Is there enough biomaterial to prepare a large dose of vaccine?
– In the vaccine manufacturing technology, the biomaterial is not prepared in advance. For each batch, the biomaterial is withdrawn and sent to the manufacture of the vaccine. Our scientists are ready to produce the vaccine in the required volume.
– At what degrees is the QazCovid-in vaccine transported and stored?
– The domestic vaccine is transported dry, without direct sunlight, at a temperature of 2-8 ° C.
– When Pfizer-Biontech and Moderna vaccines passed phase I/II trials, their results were published in the leading scientific journals The Lancet, The New England Journal of Medicine. And an article about the Russian vaccine “Sputnik V” was published recently. When will an article about QazCovid-in, made in Kazakhstan, be published in such major scientific publications? Have foreign scientists asked for the results of the tests of the vaccine produced in our country?
– An article is being prepared about the domestic QazCovid-in vaccine that meets the requirements of rating magazines, this will take some time. Foreign scientists have not requested test results, even if they ask, the results of clinical trials will not be given until they are fully completed.
– It is noted that the oldest of the volunteers who participated in the testing of the QazCovid-in vaccine was 70 years old. However, they say that the vaccine is administered only to people aged 18 to 65 years. And if people over 65, on the contrary, belong to a weaker group, then why are they not vaccinated?
– The domestic QazCovid-in vaccine is being examined by volunteers aged 18 to 65 years in accordance with the protocol approved by the Ministry of Health. Upon receipt of the results of the 3-phase trial, to vaccinate or not persons over 65 years of age will be made by the decision of medical professionals.
– In which factory will be produced QazCovid-in if it successfully passes the third phase?
– The domestic QazCovid-in vaccine will be planned to be produced at a biopharmaceutical plant, on the territory of which is under construction at the Research Institute of Biological Safety Problems (RIBSP).
– In the second phase of testing of the domestic vaccine, such famous people as Berdibek Saparbayev and Yerlan Karin were vaccinated. Are there any famous citizens among the persons participating in the third phase?
– 3-phase of clinical trials are still being conducted, information about volunteers according to the approved protocol is confidential, after the completion of the trials we will answer this question.
We will not take the vaccine
210 people took part in the survey of the “Tribune” website about which vaccine you will take. The overwhelming majority of respondents stated that they are categorically against the introduction of the vaccine.
Well, “Why don’t you want to vaccinate?” the majority replied that they were skeptical about the quality, 37.6% said that they were afraid of negative effects.
To the question “If there is a choice, which vaccine would you have?” the majority chose the American vaccine, the second domestic vaccine.
